Amgen (AMGN) Total Debt (2009 - 2026)

Amgen (AMGN) has reported Total Debt for 18 consecutive years, with $57.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Debt changed 0.1% year-over-year to $57.3 billion; the TTM figure through Mar 2026 stood at $57.3 billion (changed 0.1% YoY), while the FY2025 annual figure was $54.6 billion, down 9.14% from the prior year.
• Total Debt came in at $57.3 billion for Q1 2026 at Amgen, up from $54.6 billion in the prior quarter.
• The five-year high for Total Debt was $64.6 billion in Q4 2023, with the low at $36.5 billion in Q2 2022.
• Average Total Debt over 5 years is $54.5 billion, with a median of $57.4 billion recorded in 2025.
• Across the five-year window, Total Debt soared 68.51% in 2023 and retreated 10.37% in 2025, its largest moves.
• Year by year, Total Debt stood at $38.9 billion in 2022, then jumped by 65.91% to $64.6 billion in 2023, then fell by 6.99% to $60.1 billion in 2024, then retreated by 9.14% to $54.6 billion in 2025, then grew by 4.98% to $57.3 billion in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $57.3 billion, $54.6 billion, and $54.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.